Allogeneic hematopoietic cell transplantation involves consideration of both donor and
recipient characteristics to guide the selection of a suitable graft. Sufficient high-resolution …

Umbilical cord blood is an alternative hematopoietic stem cell source for patients with
hematologic diseases who can be cured by allogeneic hematopoietic cell transplantation …

Purpose Adult T-cell leukemia-lymphoma (ATL) is a distinct mature T-cell malignancy
caused by chronic infection with human T-lymphotropic virus type 1 with diverse clinical …

Health disparities are health differences linked with economic, social, and environmental
disadvantage. They adversely affect groups that have systematically experienced greater …

Background Umbilical-cord blood has been used as the source of hematopoietic stem cells
in an estimated 30,000 transplants. The limited number of hematopoietic cells in a single …

Purpose Over the past four decades, allogeneic hematopoietic cell transplantation (alloHCT)
has evolved as a curative modality for patients with hematologic diseases. This study …

Unrelated donor cord blood transplantation (CBT) results in disease-free survival
comparable to that of unrelated adult donor transplantation in patients with hematologic …

Only 30% of patients who require an allogeneic hematopoietic cell transplant will have an
HLA-matched sibling donor. A search for an unrelated donor will be undertaken for patients …

Transplantation of umbilical cord blood (UCB) is an attractive alternative source of
hematopoietic stem cells (HSCs). The unique properties of cord blood and its distinct …

While cord blood transplantation (CBT) is an effective therapy for hematologic malignancies,
acute graft-versus-host disease (aGVHD) is a leading cause of transplant-related mortality …